Blog
Spotlight: Mark Leahey, MDMA CEO and Fogarty Institute Board Member
Every industry needs a “voice” standing up for it, and the entrepreneurial sector of the medical device industry is fortunate to have Mark Leahey, president and CEO of the...
Q&A with Thomas J. Fogarty, MD, FII Founder and Director
Given his impressive track record for inventions and the boundless energy he exhibits at the age of 85, no one would be surprised if Dr. Fogarty announced he had created his...
Enspectra Receives Series A Funding; Moves Forward in Widening Market for Skin Cancer Detection Breakthrough
Enspectra Health, a Fogarty Institute company that is leading a digital transformation in skin cancer pathology, recently closed a $7.5 million Series A round led by Tsingyuan...
Building a Successful Roadmap to Commercialization – Recent Fogarty Institute Workshop Offers Insight on Taking Devices to Market
One of the most strategically important topics for a startup is commercialization – the point when a company transitions from research focus to generating revenue, scaling the...
Fogarty Institute Startups Make Strides; Raise Funds
It’s often said that the only constant is change. Here at the Fogarty Institute, we embrace that sentiment because in the world of medtech, change is inevitable to continue to...
Spotlight: John Morriss, FII Director of Invention Acceleration Program
As the Fogarty Institute continues to expand the services it provides its partners and companies-in-residence, John Morriss, a seasoned medtech R&D professional, joins us as...
Q&A With Eb Bright, ExploraMed President and General Counsel
A patent attorney and inventor who also has extensive experience successfully founding companies, Earl ”Eb” Bright has been an invaluable player in advancing the medical...
Tom Krummel, MD, Believes Continuous Learning Is at the Heart of a Successful Career
He almost needs no introduction, and yet, we would be remiss in not sharing a few of his finest traits: A contagious passion for our industry, an affinity for finding better...
Q&A With Jeff Elkins, COO of InterVene
Jeff Elkins, a seasoned medtech executive with experience in both startups and larger companies, was recently hired as chief operating officer of InterVene, a Fogarty Institute...